Antipsychotic Polypharmacy in Children and Adolescents at Discharge from Psychiatric Hospitalization
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy2014Vol. 34(8), pp. 836–844
Citations Over TimeTop 10% of 2014 papers
Shannon N. Saldaña, Brooks Keeshin, Anna M. Wehry, Thomas J. Blom, Michael T. Sorter, Melissa P. DelBello, Jeffrey R. Strawn
Abstract
Certain youth may have a higher likelihood of being prescribed antipsychotic polypharmacy, which should prompt careful consideration of medication treatment options during inpatient hospitalization. Future examinations of the rationale for combining antipsychotics, along with the long-term safety, tolerability, and cost effectiveness of these therapies, in youth are urgently needed.
Related Papers
- → Frequency, reasons, and factors associated with antipsychotic polypharmacy in Schizophrenia: A retrospective chart review in a tertiary hospital in India(2020)13 cited
- → Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy(2016)11 cited
- → Antipsychotic Medication Prescribing Practices Among Adult Patients Discharged From State Psychiatric Inpatient Hospitals(2016)7 cited
- → The changing global mental health landscape and need for leadership(2011)3 cited
- Causes of antipsychotic polypharmacy in schizophrenia treatment(2009)